Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
Clinical Progress
LAEKNA-B (02105.HK): LAE103 phase I SAD study completed
Tags:
LAEKNA-B
02105.HK
Clinical Progress
2026-11-09
CSPC PHARMA (01093.HK): SYH2072 Phase II trial starts
Tags:
CSPC PHARMA
01093.HK
Clinical Progress
2026-11-03
CSPC PHARMA (01093.HK): SYS6088 Phase I/II trial starts
Tags:
CSPC PHARMA
01093.HK
Clinical Progress
2026-11-03
LEADS BIOLABS-B (09887.HK): LBL-047 completes first SLE patient dosing in Phase I Part B
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Progress
2026-10-30
ASCLETIS (01672.HK): Denifanstat US phase III doses first patient
Tags:
ASCLETIS
01672.HK
Clinical Progress
2026-10-23
TENNOR THERAP (06872.HK): TNP-2092 PJI trial doses first patient
Tags:
TENNOR THERAP
06872.HK
Clinical Progress
2026-10-23
SBP GROUP (01177.HK): Kylo-11 Phase I data published in The Lancet; single dose reduces Lp(a) by up to 97% at week 48
Tags:
SBP GROUP
01177.HK
Clinical Progress
2026-08-31
TYK MEDICINES-B (02410.HK): Dovatinib mesylate tablets (TY-9591) granted conditional approval as first-line treatment for EGFR-mutant NSCLC with CNS metastases
Tags:
TYK MEDICINES-B
02410.HK
Clinical Progress
2026-08-27
FOSUN PHARMA (02196.HK): Licensed drug weliteitumab injection (GR1803) granted conditional approval for relapsed or refractory multiple myeloma
Tags:
FOSUN PHARMA
02196.HK
Clinical Progress
2026-08-27
SSY GROUP (02005.HK): Gadobutrol injection and indocyanine green for injection approved, enhancing imaging and critical care product portfolio
Tags:
SSY Group
02005.HK
Clinical Progress
2026-08-27
LIVZON PHARMA (01513.HK): Lecankitug injection approved for marketing; first domestic IL-17A/F dual-target biologic in China
Tags:
LIVZON PHARMA
01513.HK
Clinical Progress
2026-08-27
LUYE PHARMA (02186.HK): therapeutic mRNA vaccine LY01620 to initiate Phase II clinical trial in China, HPV viral clearance rate nearly 90%
Tags:
LUYE PHARMA
02186.HK
Clinical Progress
2026-08-21
LONGBIO-B (01779.HK): BLA of LP-003 for seasonal allergic rhinitis accepted by NMPA
Tags:
LongBio-B
01779.HK
Clinical Progress
2026-08-21
LEADS BIOLABS-B (09887.HK): Phase II study abstract of Vimx (opasumivimab) as first-line NSCLC therapy published on WCLC website
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Progress
2026-08-20
LEADS BIOLABS-B (09887.HK): Oblenio exercises option to retain license for LBL-051, Company to receive USD 10 million
Tags:
LEADS BIOLABS-B
09887.HK
Clinical Progress
2026-08-20
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App